← Back to All Filings

GE HealthCare Chief Commercial & Growth Officer Disposes Shares for Tax Obligations

Low SignificanceSeptember 4, 2026 at 9:08:18 PM UTC

GE HealthCare Technologies Inc.

$GEHC4CIK: 0001932393

Subscribe to track GEHC

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

šŸ“‹ Form 4 Filing Analysis: GE HealthCare Technologies Inc. ($GEHC)

Insider: Catherine Estrampes (Chief Commer. & Growth Officer) Transaction Date: September 3, 2026 Filing Date: September 4, 2026

Transaction Details: • Type: Tax Withholding (Code F) • Shares: 508 disposed • Price: $70.56 • Total Value: $35,844.48 • Remaining Direct Holdings: 23,573 shares

Significance: Low — Standard tax obligation withholding following RSU vesting.

Comprehensive Analysis

Executive Summary

On September 4, 2026, GE HealthCare Technologies Inc. ($GEHC) reported a routine Form 4 filing for Catherine Estrampes, the company's Chief Commercial & Growth Officer. The transaction took place on September 3, 2026, involving the withholding of 508 shares of common stock to satisfy tax withholding obligations associated with the vesting of restricted stock units (RSUs).

Transaction Breakdown

  • Security: Common Stock, par value $0.01 per share
  • Transaction Code: F (Payment of exercise price or tax liability by delivering or withholding securities)
  • Shares Disposed: 508
  • Price Per Share: $70.56
  • Total Transaction Value: $35,844.48
  • Post-Transaction Direct Holdings: 23,573 shares

Analysis & Significance

This transaction carries Low trading significance as it represents an automatic or mandated share withholding to cover tax liabilities rather than an open-market sale or discretionary insider sentiment trade. Catherine Estrampes retains a substantial position of 23,573 shares following the disposition.

Topics:#GEHC#GEHealthCare#InsiderTrading#Form4#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.

The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.

Always do your own due diligence and consult a licensed professional.